Afficher la couverture 'Comprehensive analysis of current approaches to inhibit regulatory T cells in cancer | Pere, Helene' en grand format
/5

0 avis

Comprehensive analysis of current approaches to inhibit regulatory T cells in cancer

Archive ouverte

Pere, Helene | Tanchot, Corinne | Bayry, Jagadeesh | Terme, Magali | Taieb, Julien | Badoual, Cecile | Adotevi, Olivier | Merillon, Nathalie | Marcheteau, Elie | Quillien, Veronique | Banissi, Claire | Carpentier, Alain | Sandoval, Federico | Nizard, Mevyn | Quintin-Colonna, Francoise | Kroemer, Guido | Fridman, Wolf H. | Zitvogel, Laurence | Oudard, Stephane | Tartour, Eric

Edité par CCSD ; Taylor & Francis -

International audience. CD4(+)CD25(+)Foxp3(+) regulatory T cells (Treg) have emerged as a dominant T cell population inhibiting anti-tumor effector T cells. Initial strategies used for Treg-depletion (cyclophosphamide, anti-CD25 mAb ...) also targeted activated T cells, as they share many phenotypic markers. Current, ameliorated approaches to inhibit Treg aim to either block their function or their migration to lymph nodes and the tumor microenvironment. Various drugs originally developed for other therapeutic indications (anti-angiogenic molecules, tyrosine kinase inhibitors, etc) have recently been discovered to inhibit Treg. These approaches are expected to be rapidly translated to clinical applications for therapeutic use in combination with immunomodulators.

Consulter en ligne

Suggestions

Du même auteur

Mucosal Imprinting of Vaccine-Induced CD8(+) T Cells Is Crucial to Inhibit the Growth of Mucosal Tumors

Archive ouverte | Sandoval, Federico | CCSD

International audience. Although many human cancers are located in mucosal sites, most cancer vaccines are tested against subcutaneous tumors in preclinical models. We therefore wondered whether mucosa-specific homi...

A CCR4 antagonist combined with vaccines induces antigen-specific CD8+ T cells and tumor immunity against self antigens.

Archive ouverte | Pere, Helene | CCSD

International audience. Regulatory T cells (Tregs) may impede cancer vaccine efficacy in hematologic malignancies and cancer. CCR4 antagonists, an emergent class of Treg inhibitor, have been shown to block recruitme...

Induction of resident memory T cells enhances the efficacy of cancer vaccine

Archive ouverte | Nizard, Mevyn | CCSD

International audience. Abstract Tissue-resident memory T cells (Trm) represent a new subset of long-lived memory T cells that remain in tissue and do not recirculate. Although they are considered as early immune ef...

Chargement des enrichissements...